|
♦ this month’s deep dive
Beyond Human Nutrition: The Three Pillars of the Nutrition Economy
Humans need vitamins, minerals, and supplements to thrive. So do animals. So do plants. There are entire industries built around each of those end markets, and right now, two of the three are significantly underappreciated by investors.
The human nutrition category, vitamins, minerals, supplements, functional foods, and the emerging GLP-1-adjacent segment, remains a real and growing market. Early-mover platforms that scaled ahead of consumer demand were rewarded handsomely. But the category is increasingly competitive: private label pressure is intensifying, multiples in the VMS segment have compressed, and the next dollar in requires a sharper edge than the last. The question for investors today is not whether human nutrition works. It is whether the best risk-adjusted returns are still found there, or whether capital should be looking at the ecosystems serving the other two pillars.
Animal Nutrition: Two Markets Inside One Sector
Animal nutrition is not one category. It is two fundamentally different investment profiles operating under the same umbrella. The first is livestock and production animal nutrition. Feed additives, including amino acids, enzymes, probiotics, mycotoxin binders, and specialty minerals, are non-discretionary inputs tied directly to global protein demand. As global protein consumption rises, the economics of feed efficiency and yield become structurally attractive. The middle market is highly fragmented, and specialty feed additive companies represent active deal targets for strategic acquirers.
The second is companion animal and pet health, a faster-growing, higher-multiple category driven by the pet humanization trend. This is not a protein consumption story. It is a veterinary care story: advanced diagnostics, therapeutics, and e-commerce channels driving premium spend on animal health rather than animal feed. The veterinary API manufacturing market is expanding materially through 2035. However, we are in the final innings of humanization. Companion pet populations are stagnant or declining and the market is largely consolidated. There will be pockets of opportunity in the segment, but the next wave of returns will be derived upstream.
Plant Nutrition: Commodity Inputs and the Value-Added Upgrade
Plant nutrition follows the same structural logic. At the commodity end, potash, nitrogen, and phosphate fertilizers are cyclical, macro-driven, and priced accordingly. They are important but not where the interesting investment activity is concentrated.
The value-added tier is a different story. Specialty crop nutrition products, including biostimulants, micronutrient blends, and biological soil amendments, are growing at multiples of the commodity market. Biologicals more broadly, spanning biostimulants, biocontrol agents, and biological inputs that improve crop health and yield, are compounding at low-to-mid-teens rates. Large-cap strategics including Corteva, Syngenta, and BASF are all running active M&A programs in this space. The “clean input” movement is real: growers are increasingly pulling for solutions that deliver yield improvements with a smaller synthetic footprint, and the middle market serving those growers is highly fragmented.
What connects all three pillars is the underlying logic: organisms, whether human, animal, or plant, need inputs to perform. The industries serving those needs share structural characteristics: fragmented middle markets, non-discretionary demand, ingredient-level pricing power, and recurring customer relationships. Human nutrition built those characteristics into recognizable investment platforms over the past decade. Animal and plant nutrition are earlier in that process.
Takeaway
The takeaway for owners and acquirers is straightforward. Across inputs and ingredients, capital is concentrating around two attributes, defensibility and market opportunity, and it will arrive through either development or consolidation to secure them. Expect more strategics to free trapped ingredient assets into the hands of sponsors, and more sponsors and strategics to compete for the pure-play platforms that already have both. The brand layer will keep making the headlines, but the layer below is where this cycle is quietly being underwritten.
|
— market sizing: the three pillars of nutrition —
|
Human Nutrition
|
|
$465B
Global Nutraceuticals Market, 2025
|
|
~7.5% CAGR
Growth Rate to 2032
|
|
Protein, functional foods, supplements, GLP-1-adjacent nutrition
|
|
|
|
Animal Nutrition
|
|
$548B
Global Animal Feed & Nutrition Market, 2025
|
|
~3% CAGR
Growth Rate to 2034 (~$699B)
|
|
Bifurcated: livestock feed efficiency + companion animal pet health
|
|
|
|
Plant Nutrition
|
|
$200B+
Global Fertilizers + Crop Inputs, 2025
|
|
~14% CAGR
Biologicals Sub-Segment to 2035
|
|
Commodity (potash, NPK) + high-growth biologicals
|
|
Sources: Human Nutrition: SNS Insider / GlobeNewswire (2025). Animal Nutrition: IMARC, Global Animal Feed Market Report (2025). Plant Nutrition: IMARC / GlobeNewswire (2025).
|
|
— tldr —
|
i.
The nutrition economy has three pillars: human nutrition (real, competitive, and maturing), animal nutrition (fragmented, bifurcated between livestock and companion animal), and plant nutrition (split between commodity inputs and a fast-growing value-added tier including biologicals).
|
i.
The value-added plant nutrition tier, including biologicals and specialty crop inputs, is growing at low-to-mid-teens rates with active M&A from Corteva, Syngenta, and BASF. The companion animal market is largely consolidated; the more compelling setup is in livestock and plant nutrition where fragmentation is highest.
|
iii.
Both animal and plant nutrition offer fragmented middle-market dynamics that reward active dealmakers. Capital is concentrating around defensibility and market opportunity, arriving through development or consolidation at innovative, independent operators lagging consumer trends.
|
|
|